KEFELİ, U. Et Al. 2013. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. ONCOLOGY LETTERS , vol.6, no.2 , 605-611.

KEFELİ, U., Benekli, M., Sevinc, A., Yildiz, R., Kaplan, M. A., Ciltas, A., ... Balakan, O.(2013). Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. ONCOLOGY LETTERS , vol.6, no.2, 605-611.

KEFELİ, UMUT Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience," ONCOLOGY LETTERS , vol.6, no.2, 605-611, 2013

KEFELİ, UMUT Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience." ONCOLOGY LETTERS , vol.6, no.2, pp.605-611, 2013

KEFELİ, U. Et Al. (2013) . "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience." ONCOLOGY LETTERS , vol.6, no.2, pp.605-611.

@article{article, author={UMUT KEFELİ Et Al. }, title={Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience}, journal={ONCOLOGY LETTERS}, year=2013, pages={605-611} }